Launching 1st March 2023. Also check out: https://www.thailandmedical.news/
Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland and is found in semen, the medium that carries sperm. PSA liquefies semen and allows sperm to swim. Small amounts of PSA are detectable in the blood of males and a serum PSA level below 4 ng/mL is considered normal. However, a PSA level between 4 and 10 ng/mL is considered suspicious and may require a repeat test.
PSA is secreted in large amounts by prostate cancer cells. As prostate cancer progresses, the blood levels of PSA begin to rise and an increased PSA level is therefore associated with an increased risk for prostate cancer. However, PSA is not a definitive test for prostate cancer and many men may still develop prostate cancer, despite having blood PSA levels under 4 ng/mL. In around 15% of all prostate cancer cases diagnosed on biopsy, the PSA level is still within the normal value range.
However, it is estimated that men who have a borderline PSA level of between 4 and 10 ng/mL have a 25% risk of developing prostate cancer and this risk is increased further still to 50% when the PSA level is above 10 ng/mL.
Prostate cancer may be suspected based on a patient's symptom profile and details such as family history of the condition, age and ethnicity. As well as a patient's PSA level being tested, a digital rectal examination (DRE) and tissue biopsy are performed to check for the presence of cancer.
Factors affecting levels of PSA include: